La viscosuplementación articular es la inyección guiada por imagen del ácido hialurónico, una sustancia que permite que sus articulaciones se deslicen suavemente. El ácido hialurónico se encuentra normalmente en rodillas jóvenes y sanas, pero con el desgaste, comienza a desaparecer. Reemplazar lo que se ha perdido, permite que la articulación se movilice en forma suave nuevamente, lo que resulta en un alivio del dolor.

El procedimiento generalmente requiere 30 minutos, incluido el tiempo de preparación y recuperación.

Se administran tres inyecciones en intervalos de una semana para completar la serie. Se puede repetir según sea necesario debido a su excelente perfil de seguridad.

La viscosuplementación articular es muy exitosa para aliviar el dolor en pacientes con artrosis leve a moderada. El beneficio de estas inyecciones generalmente ocurrirá de dos a siete días después del procedimiento final.

• Wilson M, Michet C, Ilstrup D, Melton III L. Idiopathic Symptomatic Osteoarthritis of the Hip and Knee: A Population-Based Incidence Study. Mayo Clinic Proceedings. 1990;65(9):1214-1221.

• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bulletin of the World Health Organization. 2003;81(9):646-56.

• Losina E, Walensky R, Reichmann W, Holt H, Gerlovin H, Solomon D et al. Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans. Annals of Internal Medicine. 2011;154(4):217.

• Youngcharoen P, Hershberger P, Aree-Ue S. Pain in elderly patients with knee osteoarthritis: an integrative review of psychosocial factors. International Journal of Orthopaedic and Trauma Nursing. 2017;25:19-28.

• Martínez Figueroa R, Martínez Figueroa C, Calvo Rodriguez R, Figueroa Poblete D. Osteoartritis (artrosis) de rodilla. Revista Chilena de Ortopedia y Traumatología. 2015;56(3):45-51.

• Santilli V, Paoloni M, Mangone M, Alviti F, Bernetti A. Hyaluronic acid in the management of osteoarthritis: injection therapies innovations. Clinical Cases in Mineral and Bone Metabolism. 2016; May-Aug; 13(2): 131–134.

• Bhandari M, Bannuru R, Babins E, Martel-Pelletier J, Khan M, Raynauld J et al. Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective. Therapeutic Advances in Musculoskeletal Disease. 2017. Sep;9(9):231-246.

• Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-from evidence-based medicine to the real-life setting. Semin Arthritis Rheum 2016; 45(Suppl. 4): S3–S11.

• Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence- based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62(12): 1145–1155.

• Bellamy N, et al. Cochrane Database Syst Rev, 2006.

• National Clinical Guideline Centre. London: NIHCEG, Osteoarthritis: care and management. 2014.

• Bannuru R, Kent D, McAlindon T. Pharmacologic Interventions for Knee Osteoarthritis. Annals of Internal Medicine. 2015;162(9):672.

• Campbell C and Edwards R. Ethnic differences in pain and pain management. Pain Manag. 2012 May; 2(3): 219–230.

• Maheu E, Rannou F, Reginster J. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism. 2016. Feb;45(4):S28-S33.

• Boutefnouchet T, Puranik G, Holmes E, Bell KM. Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years. Knee Surgery & Related Research. 2017;29(2):129-136.

• Altman R, Fredericson M, Bhattacharyya SK, et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg. 2016;29:564–70.

• Uçar D, Dıraçoğlu D, Süleyman T, Çapan N. Intra-Articular Hyaluronic Acid as Treatment in Elderly and Middle-Aged Patients with Knee Osteoarthritis. The Open Rheumatology Journal. 2013;7: 38-41.

• Abbott T, Altman RD, Dimef R, Fredericson M, Vad V, Vitanzo P, et al. Do hyaluronic acid injections delay total knee replacement surgery? Arthritis Rheum. 2013;65:S910–S1.

• Mar J, Romero Jurado M, Arrospide A, Enrique Fidalgo A, Soler Lopez B. Cost- analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarthritis. Rev Esp Cir Ortop Traumatol 2013;57:6–14.

• Novaes AC, Schaiquevich P, Nasswetter G. Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis. Int J Clin Pharmacol Res 2005;25(1):1–7).

• Bates MS and Edwards WT. Ethnic variations in the chronic pain experience. Ethn Dis. 1992;2:63–83.

• Rahim-Williams B, Riley III J, Williams A, Fillingim R. A Quantitative Review of Ethnic Group Differences in Experimental Pain Response: Do Biology, Psychology and Culture Matter? Pain Med, 2012; 13(4): 522–540.